Smruthi Organics Limited (BOM:540686)

India flag India · Delayed Price · Currency is INR
121.70
-1.80 (-1.46%)
At close: Jun 1, 2026
Market Cap1.41B +8.3%
Revenue (ttm)1.02B -19.1%
Net Income34.26M -3.9%
EPS2.99 -3.9%
Shares Out 11.45M
PE Ratio41.30
Forward PEn/a
Dividend1.50 (1.21%)
Ex-Dividend DateJul 31, 2026
Volume2,852
Open125.20
Previous Close123.50
Day's Range120.00 - 125.25
52-Week Range95.00 - 164.00
Beta-0.06
Analystsn/a
Price Targetn/a
Earnings DateMay 13, 2026

About Smruthi Organics

Smruthi Organics Limited manufactures and markets active pharmaceutical ingredient (API) products to India. The company provides API for cardiovascular that includes amlodipine besilate, losartan potassium, telmisartan, s - amlodipine besilate, s - amlodipine malelate, and valsartan; for anti diabetic, which comprises metformin HCL, vildagliptin, teneligliptin, and dapagliflozin; and for anti infectives that consists of ciprofloxacin HCL, diloxanide furoate, norfloxacin, and pefloxacin mesylate, as well as ticagrelor for anti platelets. It also... [Read more]

Industry Medicinal Chemicals and Botanical Products
Founded 1989
Employees 267
Stock Exchange Bombay Stock Exchange
Ticker Symbol 540686
Full Company Profile

Financial Performance

In fiscal year 2026, Smruthi Organics's revenue was 1.02 billion, a decrease of -19.08% compared to the previous year's 1.26 billion. Earnings were 34.26 million, a decrease of -3.85%.

Financial Statements